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RESUMO – Metástases cutâneas de neoplasias internas constituem um evento raro, ocorrendo em 0,9% a 4,4% em grandes 
estudos necrópsicos e atingindo 9% em grandes séries de doentes neoplásicos. Metástases cutâneas de carcinomas da tiróide 
são ainda mais raros e, entre eles, os de carcinomas foliculares foram mais raramente reportados, mais escassamente do 
que os de carcinomas papilares ou medulares.
Um Eurocaucasiano de 57 A de idade recorreu à consulta por pápula angiomatoide na área parietal do couro cabeludo, com 
cerca de 4 meses de evolução. O doente tinha sido submetido, 2 anos antes, a tiroidectomia total, complementada com ra-
dioterapia e diversos esquemas quimioterapêuticos por um carcinoma metastático de células de Hürthle da tiróide. A biópsia 
excisional da pápula permitiu estabelecer, com recurso a estudos imuno-histoquímicos, o diagnóstico de metástase cutânea 
de carcinoma folicular da tiróide. Os gânglios linfáticos, pulmões e os ossos constituem as mais prevalentes localizações à 
distância das metástases do carcinoma folicular da tiróide. Embora estas neoplasias representem até 12% das neoplasias ma-
lignas da tiróide, metástases cutâneas destes tumores têm sido muito raramente reportadas. Estes tumores são habitualmente 
carcinomas bem diferenciados, com prognóstico favorável a longo termo e caracterizados histologicamente por estruturas 
foliculares com material colóide e variáveis anaplasia e distorção arquitectural.
No caso apresentado merecem destaque a morfologia angiomatoide da lesão metastática, classicamente associada a me-
tástases de tumores de células renais e a alguns casos já relatados de tumores de células de Hürthle, bem como o compor-
tamento agressivo e a evolução fatal verificados. O caso é ilustrado iconograficamente e uma breve revisão da literatura é 
efectuada. 
PALAVRAS-CHAVE – Adenocarcinoma Folicular; Couro Cabeludo; Metástase Neoplásica; Neoplasias da Pele/secundária; 
Neoplasias da Tiróide.
Scalp Metastasis from Follicular Hürthle-Cell 
Carcinoma of the Thyroid Challenges and Follow-up 
ABSTRACT – Overall, skin metastases from internal malignancies are a rare event, ranging from 0.9% to 4.4% in large autopsy 
studies and reaching 9% in large series of patients. Skin metastases from thyroid carcinoma are even rarer and, among them, 
follicular carcinomas have seldom been reported in this context, far less so than papillary and medullary carcinomas.
A 57-year-old Caucasian male presented with an angioma-like papule on the parietal area of the scalp with a 4-month history. 
The patient had endured 2 years previously total thyroidectomy, radiotherapy and several chemotherapeutical regimens for a 
metastatic Hürthle cell carcinoma of the thyroid gland. Excisional biopsy of the nodules established the diagnosis of metasta-
tic (lung and liver) follicular cell carcinoma on plain histological and immunohistochemical grounds. Lymph nodes, lungs and 
bones are the most common sites of distant metastases of thyroid carcinomas. Although accounting for about 12% of all thyroid 
carcinomas, skin metastases from follicular carcinomas have however only rarely been reported. These tumours are usually well-
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INTRODUCTION
Metastases to the skin from internal malignancies are 
rare, ranging from 0.9% to 4.4% in large autopsy series 
and reaching up to 9% in large series.1 In spite of the fact 
that thyroid carcinoma is the commonest endocrinological 
malignancy,2 its prevalence is nevertheless quite low, repre-
senting about 1% of all diagnosed cancers (non melanoma 
skin cancers excluded!) per year, in the USA3 and, overall, 
accounting for about 0.5% of all cancers in males and 1.5% 
in females.4 Follicular thyroid carcinoma (FTC) – the second 
most common subtype, following papillary thyroid carcino-
ma – accounts for 12% of all thyroid cancers. It tends to 
present with its peak incidence at 40-50 years of age and 
is more prevalent in areas of endemic iodine deficiency, su-
ggesting that nodular goiter may predispose to its develo-
pment.5 Although usually more aggressive than papillary 
thyroid carcinoma, FTC still carries an excellent long-term 
prognosis with a 20 year mortality rate of only 25%, as re-
ported in a 197 patients series.6 Although FTC`s do have a 
propensity for vascular invasion and hematogenous disse-
mination,7 skin metastases have only scarcely been repor-
ted, circumstance that nevertheless constitute an ominous 
prognostic indicator.8
We hereby report on a 57-year-old patient that deve-
loped an angioma-like scalp metastasis in the context of a 
widely disseminated follicular thyroid carcinoma, oncocytic 
variant (Hürthle cell carcinoma).
CASE REPORT
A 57-year-old Caucasian male was examined becau-
se of a 4 mm diameter erythematous papule on the right 
parietal region of his scalp that had slowly been enlarging 
for the last 4 months. Thought to be a senile angioma or 
a pyogenic granuloma, an unsuccessful attempt to “dry it” 
with a silver nitrate pencil had previously been tried by hi-
mself. Upon examination, a 4 mm bright red papule with 
an angiomatous-looking morphology was appreciated at 
the right parietal aspect of his scalp (Fig. 1). On palpa-
tion, the lesion had also a slightly indurate, dermal quality 
which prompted the need for an excisional biopsy.
Two years earlier, follicular thyroid carcinoma – on-
cocytic, Hürthle cell variant – had been diagnosed, su-
perimposed on a 25 year duration multinodular colloid 
goiter. Total thyroidectomy was then performed, which was 
followed by adjuvant radioactive iodine-131 ablative the-
rapy. They both proved unsuccessful since, unfortunately, 
metastatic spread to the lungs (1 year later) and to the 
liver (two years later) always accompanied by sustained 
high, ever-rising serum thyroglobulin levels (from 15.9 to 
22 267 ng/mL), ensued. During this time, apart from 3 
iodine-131 ablative therapy sessions (cumulative dosing 
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-differentiated carcinomas, bearing a fair long-term prognosis and characterized pathologically by the presence of follicular 
structures and colloid material in the midst of diverse amounts of anaplasia and architectural disorganization. In our case, it is 
noteworthy the angioma-like morphology of the metastatic nodule, classically associated with renal cell carcinoma scalp me-
tastases, as well as its aggressive nature which led eventually to a fatal outcome. 
This case is ichnographically depicted and a review of the relevant literature is done.
KEYWORDS – Adenocarcinoma, Follicular; Neoplasm Metastasis; Skin Neoplasms/secondary; Scalp; Thyroid Neoplasms. 
Figure 1 - Scalp angioma-like papule.  
Figure 2 - Dermis occupied (and distorted) by an epithelial prolifera-
tion (H&E, x40).  
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450 mCi) attempts, a number of radiofrequency ablation 
procedures on both liver and lung metastases were done, 
which proved unsuccessful.
Excisional biopsy of the scalp nodule established the 
diagnosis of metastatic follicular cell carcinoma (on both 
plain H&E histological (Fig.s 2, 3, 4a and 4b) and on im-
munohistochemical slides (Fig.s 5a,5b and 6). The presen-
ce of a dermal nodular epithelial proliferation with both 
cell solid aggregations and ill-defined follicular structures 
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Figure 3 - Detailed epitelial proliferation (H&E, x100).  
Figure 4a - A folicular pattern can be appreciated (H&E, x200).  
Figure 4b - Detail of the follicular structure of the proliferation (H&E, 
x400).  
Figure 5a - Positive thyroglobulin immunostaining (TG, x100).  
Figure 5b - Thyroglobulin immunostaining (TG, x400).  
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was evident in HE sections; the cells were mildly pleo-
morphic, with eosinophilic cytoplasm and round to oval-
-shaped nuclei (Fig.s 2, 3, 4a and 4b). Immunoperoxidase 
staining analysis of the specimen showed thyroglobulin, 
thyroid transcription factor-1 (TTF-1) and CK19 full expres-
sion, CK 7 had a minimal expression while CK 20 and PSA 
had absence of labeling (Fig.s 5a,5b and 6). 
From then on, selective liver chemoembolization (li-
piodol and doxorubicin) and a systemic chemotherapy 
regimen with tyrosine kinase inhibitor sorafenib, were per-
formed with major adverse events and without significant 
benefits. By that time and in an attempt to personalize the-
rapy for an improved outcome, a thyroid carcinoma mo-
lecular study had been done which was negative both for 
BRAF (exons 11 and 15), HRAS (exon 2) and KRAS (exon 2) 
mutations and for RET/PTC, PAX8 PPARg gene rearrange-
ments. Recently, adding to the previously diagnosed metas-
tatic locations, skeletal metastases at the thoracic portion 
of the spine, on the left humerus and scapula were also 
detected, which have prompted for initiation of second line 
systemic sunitinib. Again, these attempts did not succeed 
and, eventually the patient died, 7 and a half years after 
the initial diagnosis.
DISCUSSION
Primary thyroid malignancies are not rare, accoun-
ting for approximately 1% of all newly diagnosed cancers. 
Differentiated thyroid carcinomas are the most frequent 
thyroid malignant neoplasms, accounting papillary and 
follicular carcinomas for the majority of the cases (80 and 
12% respectively).8 Follicular carcinoma lacks the typical 
microscopic nuclear features of papillary carcinoma and 
frequently shows transcapsular and/or signs of vascular 
invasion. Hürthle cell carcinoma is considered a variant 
of follicular carcinoma that is pathologically characterized 
by abundance of follicular cells with oncocytic features (> 
75% of tumor mass).9 Some authors consider the onco-
cytic variant a distinct subtype of Thyroid cancer due to 
its unique gross, microscopic, behavioral and cytogene-
tic features.10 Despite being distant metastasis and disease 
recurrence more common in patients with Hürthle cell car-
cinoma,11 data regarding skin metastases are still scarce.
Cutaneous metastases of differentiated thyroid carci-
nomas are quite unusual. They are even more rarely the 
initial presentation of a hitherto unknown thyroid primary 
malignancy,12 usually heralding an already widely dissemi-
nated disease.
In particular, the rarity of follicular thyroid carcinoma 
(FTC) metastatic to the skin is reflected by the fact that only 
18 cases have so far been reported in the English lan-
guage literature (8).13-18 Overall, females outnumber males 
(12:6); the mean age at presentation is about 65 (41-85), 
with locations of the skin metastases being the scalp (13 
pts), neck (3 pts), face (2 pts) and others (2 pts).13-18 Cli-
nically, they mostly present as asymptomatic skin-colored 
or red, angioma-like, firm and mobile dermal and sub-
cutaneous papules and nodules that range in size from 
a few millimeters to several centimeters in diameter and 
that can occasionally erode and ulcerate both superficially 
and deeply, into the bone.19 A vascular appearance has 
indeed been identified in these lesions, to the point of even 
showing a pulsatile character upon Doppler echography.20 
In the differential diagnosis, several benign and malignant 
lesions should be evoked, including angioma, pyogenic 
granuloma, Kaposi’s sarcoma, angiosarcoma, renal cell 
and hepatocarcinoma scalp metastases.21
Final diagnosis is however established by histological 
examination of a tissue specimen with additional immuno-
histochemical and/or EM approaches, in order to clearly 
ascertain the nature and origin of the primary malignancy. 
Fine needle aspiration cytology has also been successfully 
used in this context.15 With regard to plain HE histological 
sections, in a nodular dermally located lesion with an epi-
thelial phenotype, several other diagnoses should be ruled 
out, including adnexal skin tumors, metastatic prostate, 
bronchopulmonary and gastrointestinal adenocarcinoma. 
In our patient`s case, the known existence of a widely me-
tastatic follicular thyroid carcinoma led us to value it as 
the probable primary tumor. Such hypothesis was further 
corroborated by thyroglobulin, TTF1 and CK19 positive la-
beling. On the other hand, the negative or faintly positive 
focal immunolabeling with CK7, CK20 and PSA allowed us 
to rule out respectively lung, gastrointestinal and prostatic 
origins.  
Metastatic disease is the primary cause of death in 
follicular thyroid carcinoma. Age above 45, Hürthle cell 
variant, primary tumor size exceeding 4 cm, extrathyroi-
dal extension and the presence of distant metastasis at 
presentation usually portend a worse prognosis.22 Howe-
ver, even when faced with disseminated malignancy, with 
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Figure 6 - Thyroid transcription factor-1 immunostaining (TTF-1, 
x400). 
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appropriate management, long-term survival rates of up to 
43% have been reported.23 
Our patient did comply with the literature data as far 
as age; as a long lasting predisposing condition – multino-
dular colloid goiter; as clinical presentation, both in what 
location and morphology are concerned; as the uniformly 
unresponsiveness of the several chemotherapy regimens –
systemic and regional- that have been tried and, lastly, as 
far as clinical aggressiveness and ominous course. 
Scalp is indeed a distinct skin area characterized by a 
rich dermal vasculature; hence, not surprisingly, it is a site 
of varied secondary neoplasms. In fact, lung, breast, co-
lorectal and renal carcinomas, among others, have been 
reported to metastasize to the scalp.24 Metastatic scalp le-
sions are usually a serious diagnostic challenge. As they 
can greatly vary in appearance, a high index of clinical 
suspicion is required in order not to miss the diagnosis and 
further compromise patient`s survival chances. 
In sum, the case of a 57-year-old male patient with 
a metastatic Hürthle cell follicular thyroid carcinoma that 
presented with a scalp dermal papule is reported. In our 
patient`s case, it is noteworthy the morphology of the 
papule that easily evoked a vascular lesion; the overtly 
aggressive nature of the primary, probably due its onco-
cytic nature and, finally, the fact that the presence of a skin 
metastasis usually portends a dismal prognosis. 
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